awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38964974-82BBE7FE-C59A-41AB-969D-028C700ECC19
Q38964974-82BBE7FE-C59A-41AB-969D-028C700ECC19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38964974-82BBE7FE-C59A-41AB-969D-028C700ECC19
The development of targeted new agents to improve the outcome for children with leukemia.
P2860
Q38964974-82BBE7FE-C59A-41AB-969D-028C700ECC19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38964974-82BBE7FE-C59A-41AB-969D-028C700ECC19
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2b5e0fc32bd1eacaade9e09978175d01ed0276d5
P2860
A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.